MedTrace Logo

Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

NCT00315588 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2017-04-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to reverse hyperglycemia and insulin dependency, by islet cell transplantation, in patients with type 1 diabetes mellitus who have a stable kidney allograft.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DRUG

Islet Transplantation

Islet Transplantation in subjects with a previous kidney transplant.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • Diabetes Research Institute Foundation

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Rodolfo Alejandro

    lead OTHER

Principal Investigators

  • Rodolfo Alejandro, M.D. · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315588 on ClinicalTrials.gov